LDOS vs TERN · P/E 16, rev $16.66B vs $6.12B cap
Leidos Holdings Inc (LDOS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the LDOS and TERN stock pages for the full models.
Not investment advice.